Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo

 

Miami, FL-- (InvestorsHub NewsWire – November 7, 2023) – EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Epazz, Inc. (OTC Pink: EPAZ).

 

 

Epazz, Inc. (OTC Pink: EPAZ) A mission-critical provider of drone technology, artificial intelligence software, cryptocurrency apps, blockchain mobile apps, and cloud-based business software solutions, is making remarkable strides with its holdings, ZenaDrone, Inc.

 

Epazz, Inc. (OTC Pink: EPAZ) is gearing up to demonstrate the ZenaDrone 1000 under extreme weather conditions in collaboration with the US Navy.

 

See the full release here.

 

The U.S. Navy is looking to use the ZenaDrone 1000 for a variety of missions, including surveillance, search and rescue and reconnaissance. 

 

This groundbreaking experiment marks ZenaDrone's initial venture into assessing their technology in frigid temperatures. The ZenaDrone 1000 has already demonstrated its prowess under scorching conditions exceeding 120 degrees Fahrenheit, a testament to its durability. Now, it's time to put it to the test in sub-zero temperatures as low as negative 20 degrees. Following this cold-weather trial, the drone will be dispatched to an overseas military base, where it will be subjected to real-world scenarios, presenting a significant opportunity for the company to showcase the ZenaDrone 1000's capabilities.

 

Epazz, Inc. (OTC Pink: EPAZ) previously announced on Septemb er 28th that high ranking U.S. Navy personnel have chosen ZenaDrone 1000 to showcase its capabilities in a major presentation.

 

The company further wrote on the issue that they had been "very successful this year in gaining the attendance of multiple branches of the U.S. military. The U.S. Navy is another branch that is interested in the capabilities of ZenaDrone 1000. We have already begun preparing the ZenaDrone 1000 for the U.S. Air Force, U.S. Marine Corps and U.S. Army. Furthermore, the company presented the solution to the Department of Homeland and has a flight demonstration scheduled with the Department of Defense next month."

 

Epazz, Inc. worked to obtain the required certifications and licenses to become a defense contractor. We are also actively engaged in negotiating pilot programs with the US Air Force, having already received a letter of support. Unmanned Aerial Vehicles (UAVs), like the ZenaDrone 1000, are one of the key emerging technologies sought after by the Navy and other branches of the US military.

"We are thrilled to embark on the cold-weather testing of the ZenaDrone 1000. This presents a unique opportunity to exhibit the drone platform's capabilities," remarked Shaun Passley, CEO of Epazz Holdings.

The ZenaDrone 1000 is a versatile multi-mission UAV, designed for various payloads and includes sensors and HD cameras. It can be operated remotely or autonomously, offering a cost-effective alternative to manned aircraft due to its streamlined design that doesn't require space and equipment for onboard human operators.

 

 

We currently have invitations out for many companies to present on our conference including:

 

Nate's Food Company (OTC Pink: NHMD)

Good Vibrations Shoes, Inc. (OTC Pink: GVSI)

Northwest Biotherapeutics (OTCQB: NWBO)

BlackStar Enterprise Group, Inc. (OTC Pink: BEGI)

AB International Group Corp. (OTC Pink: ABQQ)

 

About Epazz Inc. (https://www.epazz.com/)

Epazz is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher-education institutions, and the public sector. Epazz BoxesOS™ v3.0 is a complete business web-based software package for small- to mid-sized businesses, Fortune 500 enterprises, government agencies and higher education institutions. BoxesOS™ provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz's other products are DeskFlex™ (room-scheduling software) and Provitrac™ (an applicant-tracking system).

 

About ZenaDrone (https://www.zenadrone.com)

ZenaDrone is dedicated to improving intelligent UAV technology that incorporates machine learning software and AI. It was created to revolutionize the hemp farming sector and later evolved into an intelligent multifunctional industrial surveillance, inspection and monitoring solution.

 

Safe Harbor

The Safe Harbor statement under the Private Securities Litigation Reform Act of 1995 reads as follows:

Certain statements contained in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by the use of diction such as "may," "expect," "intend," "estimate," "anticipate," "believe" and "continue" (or the negatives thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from future results or those implied by such statements. Investors are cautioned that any forward-looking statement does not guarantee future performance and that actual results may differ materially from those contemplated by such statements. Epazz Inc. assumes no obligation and has no intention of updating these forward-looking statements, and it has no obligation to update or correct information prepared by third parties that are not paid for by Epazz Inc. Investors are encouraged to review Epazz Inc.'s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC markets filings, which contain general business information about the company's operations, results of operations and risks associated with the company and its operations.

 

About EmergingGrowth.com

Founded in 2009, EmergingGrowth.com quickly became a leading independent small cap media portal.  Over the years, it has developed an extensive history of providing unparalleled content, in identifying emerging growth companies and markets that can be overlooked by the investment community.

The next step in its evolution is the Emerging Growth Conference.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in an effective and time efficient manner.

The audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

If you believe your company, product or service is at the cusp of going mainstream, or you have an idea for an "Emerging Growth" company that might fit our model, contact us here.

All Conferences are first announced on Twitter – Follow us on Twitter

All Conference replays emerge on our YouTube Channel – Subscribe to our YouTube Channel

All sessions are conducted through video webcasts and will take place in the Eastern time zone. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

This is an advertisement and not an offer or solicitation to buy or sell any securities.  All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is not the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. EmergingGrowth.com has been compensated seven thousand five hundred dollars by Epazz, Inc. for distribution of this content.  EmergingGrowth.com has also received additional past compensation and EmergingGrowth.com may  receive future compensation, details about which can be found in our full disclosure, here, https://emerginggrowth.com/3729-6827465/.  You can easily lose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

 

CONTACT:

Company: EmergingGrowth.com - http://www.EmergingGrowth.com

Contact Email: info@EmergingGrowth.com

SOURCE: EmergingGrowth.com

 

Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Northwest Biotherapeutics (QB) Charts.
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Northwest Biotherapeutics (QB) Charts.